Results 31 to 40 of about 536 (108)
Pharmaceutical-Induced Dyskinesia: A Case Study of Thoracotomy Treated with Amantadine
Case Reports in Clinical PracticeDyskinesia, marked by involuntary and irregular movements, can result from various pharmaceutical agents. The case presented features a patient undergoing thoracotomy, experiencing dyskinesia, likely attributed to antipsychotics, antiemetics, and ...
Mojtaba Mojtahedzadeh +3 more
doaj +1 more source
Biomedicines, 2022 Evidence about the use of pharmacologic agents in the treatment of Anorexia Nervosa (AN) is lacking, especially in childhood and adolescence. A systematic scoping review was conducted to outline current literature evidence about the use of antipsychotics
Jacopo Pruccoli +3 more
doaj +1 more source
Therapeutic Advances in Psychopharmacology, 2022 Tardive dyskinesia (TD) is a movement disorder that can develop with the use of dopamine receptor-blocking agents and is most commonly caused by antipsychotics.
Yasuhiro Mori +2 more
doaj +1 more source
Clozapine-induced rabbit syndrome: a case report
Mental Illness, 2009 Rabbit syndrome (RS) is an antipsychoticinduced rhythmic motion of the mouth/lips resembling the chewing movements of a rabbit. The movement consists of a vertical-only motion, at about 5 Hz, with no involvement of the tongue.
Cicek Hocaoglu
doaj +1 more source
Oculogyric crisis with atypical antipsychotics: A case series
Indian Journal of Psychiatry, 2017 Oculogyric crisis (OGC) is an acute dystonic reaction, commonly seen with the administration of typical antipsychotics, and rarely reported with atypical antipsychotics.
Naresh Nebhinani, Navratan Suthar
doaj +1 more source
Current and Emerging Therapies for the Management of Bipolar Disorders
Journal of Central Nervous System Disease, 2011 Bipolar disorder is a complex condition to treat because agents that may be effective for a specific phase may not be effective for other phases, or may even worsen the overall course of the illness.
Rif S. El-Mallakh +4 more
doaj +1 more source
The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents
IBRO Reports, 2019 This study was designed with the rational aim of discussing the emerging antidepressant agents that are likely to bring positive landmark, tremendous improvement and significant impact to the management of patients with depression disorders.
Olumuyiwa John Fasipe
doaj +1 more source
The association between hormones and antipsychotic use: a focus on postpartum and menopausal women
Therapeutic Advances in Psychopharmacology, 2019 During the postpartum and menopausal periods of women’s lives, there is a well-established and significant drop of circulating estrogens. This may be the reason why both these periods are associated with an increased risk for onset or exacerbation of ...
Alexandre González-Rodríguez +1 more
doaj +1 more source
Prevention of Post-operative Delirium in the Elderly Using Pharmacological Agents
Canadian Geriatrics Journal, 2016 Introduction Post-operative delirium (POD) is a serious surgical complication that can cause significant morbidity and mortality. It is associated with prolonged hospital stay, delayed admission to rehabilitation programs, persistent cognitive deficits,
Patrice Tremblay, Susan Gold
doaj +1 more source
BMC Psychiatry, 2009 Background Nonadherence with antipsychotic medication is an important clinical and economic problem in the treatment of schizophrenia. This study identified treatment patterns and clinical characteristics that immediately precede the initiation of depot ...
Montgomery William +4 more
doaj +1 more source